We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bishop Score, Cervical Length and Multiple Proteins in Cervicovaginal Fluid at 40 Weeks to Predict Onset of Labor

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01402310
First Posted: July 26, 2011
Last Update Posted: December 10, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Seoul National University Hospital
March 17, 2011
July 26, 2011
December 10, 2013
November 2008
September 2012   (Final data collection date for primary outcome measure)
Onset of labor/delivery ≤10days [ Time Frame: Baseline ]
Same as current
Complete list of historical versions of study NCT01402310 on ClinicalTrials.gov Archive Site
Cesarean delivery in labor [ Time Frame: Baseline ]
  1. Time to onset of spontaneous labor
  2. Postterm delivery (≥40 + 11 weeks of pregnancy)
  3. The rate of cesarean delivery
Same as current
Not Provided
Not Provided
 
Bishop Score, Cervical Length and Multiple Proteins in Cervicovaginal Fluid at 40 Weeks to Predict Onset of Labor
Not Provided
The purpose of this study is to compare Bishop score, sonographic cervical length and multiple proteins in cervicovaginal fluid at 40 weeks gestation to predict time to spontaneous labor and mode of delivery.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
cervicovaginal fluid
Probability Sample
Single tertiary hospital
Prolonged Labor
Other: Ultrasound and digital cervical examination
Cervical length by transvaginal ultrasound Bishop score by digital examination Take cervicovaginal samples
Women attending antenatal clinic
Women attending antenatal clinic were consecutively enrolled at between 39+6 and 40+1 weeks of gestation.
Intervention: Other: Ultrasound and digital cervical examination
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
220
September 2012
September 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Women between 39+6 and 40+1 weeks of gestation
  • singleton pregnancy
  • viable fetus with vertex presentation
  • intact amniotic membranes
  • no pregnancy complications
  • absence of labor
  • no history of previous uterine surgery
  • planned vaginal delivery
Sexes Eligible for Study: Female
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT01402310
BS_CL_40wk
No
Not Provided
Not Provided
Seoul National University Hospital
Seoul National University Hospital
Not Provided
Principal Investigator: Kyo Hoon Park, MD, PhD Seoul National University Bundang Hospital
Seoul National University Hospital
December 2013
To Top